PCVX – vaxcyte, inc. (US:NASDAQ)
Stock Stats
News
Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines
Vaxcyte to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on February 24, 2026 [Yahoo! Finance]
Vaxcyte to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on February 24, 2026
Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit
Vaxcyte Funding And Late-Stage Trials Put Valuation In Focus [Yahoo! Finance]
Form 8-K Vaxcyte, Inc. For: Jan 29
Form 424B5 Vaxcyte, Inc.
Form 424B5 Vaxcyte, Inc.
Form 4 Vaxcyte, Inc. For: Jan 14 Filed by: GUGGENHIME ANDREW
Form 4 Vaxcyte, Inc. For: Jan 14 Filed by: PICKERING GRANT
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.